跳至主要内容
临床试验/IRCT2016060526630N2
IRCT2016060526630N2已完成3 期

Bronchodilator Effect of Nebulized Hypertonic 3% Saline in Asthma Attack

Vice challencor for reasearch of Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 337 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
337

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 139 years(—)
性别
All

入选标准

  • Inclusion Criteria: Acute Asthma Attack with: Age above 15 years old; Clinically or Para-clinically Asthma History

排除标准

  • History of Cardiovascular Diseases; History of COPD; History of other pulmonary diseases; History of Smoking more than 10 years; Pregnant women; Systolic Blood Pressure less than 100 mmHg

研究者

发起方
Vice challencor for reasearch of Ahvaz Jundishapur University of Medical Sciences

相似试验